NFE2L2 and liver cancer: There is growing evidence that gain-of-function mutations in the gene that encodes for Nrf2 is often associated with mutations of the CTNNB1 gene encoding β-catenin in liver cancer, suggesting an association between these two pathways in liver tumorigenesis [[21], [22], [23], [24], [25]].